Treatment of complex regional pain syndrome (CRPS) using low dose naltrexone (LDN)

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 3, 2013, Pages 470-476

  Chopra, Pradeep ^a   Cooper, Mark S ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allodynia; Chronic pain; Complex regional pain syndrome; Conversion disorder; CRPS; Dystonic spasms; Fixed dystonia; Functional movement disorder; LDN; Naltrexone; Neuropathic pain; Reflex sympathetic dystrophy; RSD; Ulceration; Vasomotor

Indexed keywords

ASCORBIC ACID; BACLOFEN; BOTULINUM TOXIN A; BUDESONIDE; CARNITINE; CLORAZEPATE; DIPHENHYDRAMINE; DULOXETINE; ETIRACETAM; FISH OIL; HYDROCODONE; KETAMINE; LANSOPRAZOLE; LEVALBUTEROL; MAGNESIUM; METFORMIN; MIDODRINE; NALTREXONE; OXYCODONE; PARACETAMOL; PREGABALIN; SIMVASTATIN; TAPENTADOL; TRAMADOL; TRAZODONE; UBIDECARENONE; VALSARTAN; VITAMIN B COMPLEX; VITAMIN D;

ABSCESS; ABSENCE OF SIDE EFFECTS; ADULT; ALLODYNIA; ANALGESIA; ANKLE DISLOCATION; ASTHMA; BLISTER; BODY TEMPERATURE; CASE REPORT; CHILD; CHRONIC GASTRITIS; COMPLEX REGIONAL PAIN SYNDROME; CONVERSION DISORDER; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DYSAUTONOMIA; DYSESTHESIA; DYSTONIA; EHLERS DANLOS SYNDROME; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEG INJURY; LOW DRUG DOSE; MALE; MUSCLE SPASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN ASSESSMENT; PAIN THRESHOLD; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOGENIC NONEPILEPTIC SEIZURE; REMISSION; REVIEW; SCHOOL CHILD; SHOULDER DISLOCATION; SKIN DISCOLORATION; SKIN ULCER; SWELLING; THYROID TUMOR; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL IMPAIRMENT; WEAKNESS;

CHILD; COMPLEX REGIONAL PAIN SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 84878778872     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9451-y     Document Type: Review

References (56)

1. Bailey J, Nelson S, Lewis J, McCabe CS (2012) Imaging and clinical evidence of sensorimotor problems in CRPS: utilizing novel treatment approaches. J Neuroimmune Pharmacol (Epub ahead of print)
2. Barbosa IG, Rocha NP, Huguet RB, Ferreira RA, Salgado JV, Carvalho LA, Pariante CM, Teixeira AL (2012) Executive dysfunction in euthymic bipolar disorder patients and its association. J Affect Disord 137:151-155
3. Besedovsky HO, del Rey A (2011) Central and peripheral cytokines mediate immune-brain connectivity. Neurochem Res 36:1-6
4. Binkley K (2012) Improving the diagnosis and treatment of CRPS: insights from a clinical immunologist's personal experience with an underrecognized neuroinflammatory disorder. J Neuroimmune Pharmacology (Epub ahead of print)
5. Birklein F, Riedl B, Sieweke N, Weber M, Neundörfer B (2000) Neurological findings in complex regional pain syndromes - analysis of 145 cases. Acta Neurol Scand 101:262-269
6. Church AJ, Dale RC, Giovannoni G (2004) Anti-basal ganglia antibodies: a possible diagnostic utility in idopathic movement disorders? Arch Dis Child 89:611-614
7. Cohen HE, Hall J, Harris N, McCabe CS, Blake DR, Jänig W (2012) Enhanced pain and autonomic responses to ambiguous visual stimuli in chronic Complex Regional Pain Syndrome (CRPS) type I. Eur J Pain 16:182-195
8. Cooper MS (2011) Nerve injuries and the fixed dystonias of CRPS. Pain Med 12:842-843
9. Cooper MS, Clark VP (2012) Neuroinflammation, neuroautoimmunity, and the co-morbidities of CRPS. J Neuroimmune Pharm (Epub ahead of print)
10. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, de Koninck Y (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 15:1017-1021
11. Del Valle L, Schwartzman RJ, Alexander G (2009) Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain Behav Immun 23:85-91
12. Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia 61:349-60
13. Fong CY, de Sousa C (2006) Childhood chorea-encephalopathy associated with human parvovirus B19 infection. Dev Med Child Neurol 48:526-528
14. Grillo E, da Silva RJ (2009) Childhood chorea-encephalopathy and unremarkable MRI: an association suggesting parvovirus B19 infection. Dev Med Child Neurol 51:759-761
15. Hawley JS, Weiner WJ (2011) Psychogenic dystonia and peripheral trauma. Neurology 77:496-502
16. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier SF, Rice KC, Watkins LR (2008) Non-steroselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 28:20-29
17. Javed S, Sharples PM, Khan S, White E, Gill S (2011) Recovery from fixed dystonia in complex regional pain syndrome type 1 (CRPS-1) following deep brain stimulation (DBS) surgery. Arch Dis Child 96(Suppl 1):A81
18. Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, Kavelaars A, Verney C, Mantz J, Gressens P (2012) Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 72:536-49
19. Kharkar S, Ambady P, Venkatesh Y, Schwartzman RJ (2011a) Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review. Pain Phys 14:419-24
20. Kharkar S, Ambady P, Yedatore V, Schwartzman RJ (2011b) Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome. Pain Phys 14:311-316
21. Kohr D, Singh P, Tschernatsch M, Kaps M, Pouokam E, Diener M, Kummer W, Birklein F, Vincent A, Goebel A, Wallukat G, Blaes F (2011) Autoimmunity against the b(2) adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 152:2690-2700
22. Kolb L, Lang C, Seifert F, Maihöfner C (2012) Cognitive correlates of "neglect-like syndrome" in patients with complex regional pain syndrome. Pain 153:1063-1073
23. Leow-Dyke S, Allen C, Denes A, Nilsson O, Maysami S, Bowie AG, Rothwell NJ, Pinteaux E (2012) Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J Neuroinflammation 9:230
24. Linnman C, Becerra L, Borsook D (2012) Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain. J Neuroimmune Pharmacology (Epub ahead of print)
25. Liu B, Du L, Hong JS (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607-617
26. Maihöfner C, Peltz E (2011) CRPS, the parietal cortex and neurocognitive dysfunction: an emerging triad. Pain 152:1453-1454
27. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F (2003) Patterns of cortical reorganization in complex regional pain syndrome. Neurology 61:1707-1715
28. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F (2004) Cortical reorganization during recovery from complex regional pain syndrome. Neurology 63:693-701
29. Mao-Ying QL, Wang XW, Yang CJ, Li X, Mi WL, Wu GC, Wang YQ (2012) Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain 5:16
30. Marinus J, Moseley GL, Birklein F, Baron R, Maihöfner C, Kingery WS, van Hilten JJ (2011) Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 10:637-648
31. Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23-36
32. Mitchell SW (1872) Injuries of nerves and their consequences. J.B. Lippincott & Company
33. Mitchell MC, Memisoglu A, Silverman BL (2012) Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection. J Stud Alcohol Drugs 73:991-997
34. Moriwaki K, Yuge O, Tanaka H, Sasaki H, Izumi H, Kaneko K (1997) Neuropathic pain and prolonged regional inflammation as two distinct symptomatological components in complex regional pain syndrome with patchy osteoporosis - a pilot study. Pain 72:277-282
35. Oaklander AL, Fields HL (2009) Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol 65:629-638
36. Ochoa JL, Verdugo RJ (1995) Reflex sympathetic dystrophy. A common clinical avenue for somatoform expression. Neurol Clin 13:351-363
37. Raja SN (2009) Motor dysfunction in CRPS and its treatment. Pain 143:3-4
38. Rea F, Bell JR, Young MR, Mattick RP (2004) A randomized, controlled trial of low dose naltrexone for the treatment of opioid dependence. Drug Alcohol Depend 75:79-88
39. Rolan P, Hutchinson M, Johnson K (2009) Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother 10:2897-2904
40. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J (2007) A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3:291-296
41. Schouten AC, van de Beek WJ, van Hilten JJ, van der Helm FC (2003) Proprioceptive reflexes in patiens with reflex sympathetic dystrophy. Exp Brain Res 151:1-8
42. Schwartzman RJ, Erwin KL, Alexander GM (2009) The natural history of complex regional pain syndrome. Clin J Pain 25:273-280
43. Schwenkreis P, Janssen F, Rommel O, Pleger B, Völker B, Hosbach I, Dertwinkel R, Maier C, Tegenthoff M (2003) Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology 61:515-519
44. Sibanc B, Lesnicar G (2002) Complex regional pain syndrome and lyme borreliosis: two different diseases? Infection 30:396-399
45. Sudeck PHM (1901) Uber die akute (reflektorische) Knochenatrophie nach Entzundungen und Verletzungen an den Extremitaten und ihre klinischen Erscheinungen. Fortschr Geb Rontgenstr 5:277
46. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102:5856-5861
47. van de Warrenburg BPC, Cordivari C, Brown P, Bhatia KP (2007) Persisting hyperekplexia after idiopathic, self-limiting brainstem encephalopathy. Mov Disord 22:1017-1020
48. van Hilten JJ (2010) Movement disorders in complex regional pain syndrome. Pain Med 11:1274-1277
49. van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhass EM (2000) Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 343:625-630
50. van Hilten JJ, van de Beek WJ, Vein AA, van Dijk JG, Middlekoop HA (2001) Clinical aspects of multifocal or generalized tonic dystonia in reflex sympathetic dystrophy. Neurology 56:1762-176
51. van Hilten JJ, Rooijen DE, Geraedts EJ, Marinus J, Jankovic J (2011) Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry 82:892-898
52. van Rijn MA, Marinus J, Putter H, Bosselar SR, Moseley GL, van Hilten JJ (2011) Spreading of complex regional pain syndrome: not a random process. J Neural Transm 118:1301-1309
53. Verdugo RJ, Ochoa JL (2000) Abnormal movements in complex regional pain syndrome. Muscle Nerve 23:198-205
54. von Hehn C, Baron R, Woolf CJ (2012) Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Cell 73:638-651
55. Watkins LR, Hutchinson MR, Rice KC, Maier SF (2009) The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30:581-591
56. Younger J, Mackey S (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 10:663-672